Investing, US News

EMA Pushes For Approval Of Novavax Vaccine

vaccine czar Novavax Vaccine

The European Medicines Agency (EMA) recommended the authorization of Novaxovid, a new COVID-19 vaccine by American biotechnology company Novavax, Inc. (NASDAQ:NVAX) to be used in people aged +18 years. It is set to become the fifth vaccine to bolster the world’s arsenal against the pandemic. Q3 2021 hedge fund letters, conferences and more Lined Up […]

Jump To The Original Source

Facebook Comments

Check Also

How do I buy puts on the world

submitted by /u/Cool-Stock8685 [link] [comments] ...

Archives